Volrustomig

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

AstraZeneca ends a Phase 3 lung cancer drug trial for volrustomig after a formal review determines success is unlikely.

8 sources 8 articles v 28 1h ago